Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC-INDEX(TM) Updated thru MAY 2009
    - OnBioVC MAY Trend Analysis, now available
    - OnBioVC JUN Trend Analysis, coming soon
    - OnBioM&A coming 2H09
    - OnBioIPO coming 2H09
  • SEARCH THE OnBioVC DATABASE:

  • bio venture capital bioscience research parks life science campuses

VytronUS (Sunnyvale, CA) a stealth, assumed early-stage cardiac medical device company focused on cardiology, closed an $11M Series B financing. Participants include Delphi Ventures and New Enterprise Associates.

Gyros (Sweden) a commercial-stage provider of platform-based tools for therapeutic protein assay optimization, closed a $10.4M Series C* financing. Participants include SLS Invest and Industrifonden.

*Investment round undisclosed

Savara Pharmaceuticals (Austin, TX) a preclinical-stage developer of dry powder and nebulized-based therapeutic inhalation drug delivery platform, closed a $1.0M Series A financing. Participants were not identified.

Embrella Cardiovascular (Malvern, PA) an early-stage medical device company focused on cerebral embolic protection during cardiovascular procedures, closed a $5.1M Series B financing. Participants include BioStarVentures, Edwards Lifesciences and MedFocus Fund.

Capella (Ireland) a development-stage medical device company focused on stents for bifurcation vascular disease complex coronary artery disease, cloased a $17.3M Series C financing. Participants include Fountain Healthcare Partners, Mitsui & Co., Enterprise Ireland, Polytechnos Partners and ACT Venture Capital.

Solazyme (San Francisco, CA) a development-stage biofuels company focused on the bioproduction of microalgae molecules for the energy, chemical, and nutraceutical industries, closed a $57M Series C financing. Participants include Braemar Energy Ventures, Lightspeed Venture Partners, VantagePoint Venture Partners, Roda Group and Harris & Harris Group.

NanoString Technologies (Seattle, WA) a commercial-stage developer of instrumentation and assays for multiplexed detection and quantification of gene expression, closed a $30M Series C financing. Participants include Clarus Ventures, OVP Venture Partners and Draper Fisher Jurvetson.

Inspire Medical Systems (Minneapolis, MN) an early-stage medical device company developing an implantable therapeutic device for the treatment of obstructive sleep apnea, closed a $17M Series B financing. Participants include Kleiner Perkins Caufield & Byers, Medtronic and U.S. Venture Partners.

Spiracur (Redwood City, CA) and early-stage medical device company focused on wound healing, closed a $20.3M Series B financing. Participants include Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures.

Inimex Pharmaceuticals (Canada) a clinical-stage biopharmaceutical company focused on infectious diseases and inflammatory disorders, closed a $22M Series B financing. Participants include Morningside, Roche Venture Fund, Astellas Venture Management, Advantage Life Science Fund, BC Advantage Funds, BDC Venture Capital, British Columbia Discovery Fund, Canadian Medical Discovery Fund, and Working Opportunity Fund.

« Previous Entries  

to top of page...


 
  • OnBioVC is Here for You!

    Let us know what data you would like to see. Contact info@OnBioVC.com